ModelEdge

Amarantus Bioscience Holdings Inc.
0001424812
Filing Type8-K
Filing Date3/27/2017
Updated3/28/17, 10:02 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
EX-3.1CERTIFICATE OF DESIGNATION OF SERIES F PREFERRED STOCK FILED WITH THE NEVADA SECRETARY OF STATE ON MARCH 9, 2017
EX-3.2CERTIFICATE OF AMENDMENT OF THE CERTIFICATE OF DESIGNATIONS FOR THE SERIES E CONVERTIBLE PREFERRED STOCK FILED WITH THE NEVADA SECRETARY OF STATE ON MARCH 27, 2017
EX-3.3CERTIFICATE OF AMENDMENT OF THE CERTIFICATE OF DESIGNATIONS FOR THE SERIES H CONVERTIBLE PREFERRED STOCK FILED WITH THE NEVADA SECRETARY OF STATE ON MARCH 27, 2017
EX-10.1FORM OF CONTINGENT SETTLEMENT AGREEMENTS FOR SENIOR SECURED CONVERTIBLE DEBENTURE HOLDERS
EX-10.2FORM OF CONTINGENT SETTLEMENT AGREEMENTS FOR CONVERTIBLE SERIES E PREFERRED STOCK HOLDERS
EX-10.3FORM OF CONTINGENT SETTLEMENT AGREEMENTS FOR CONVERTIBLE SERIES H PREFERRED STOCK HOLDERS
EX-10.4SECURITIES PURCHASE AGREEMENT, ENTERED INTO ON MARCH 6, 2017, BY AND AMONG AMARANTUS BIOSCIENCE HOLDINGS, INC. AND AMARANTUS BIOSCIENCE PTE, LTD.
EX-99.1Material Contracts, Unregistered Sales of Equity Securities, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Other Events
GRAPHICGraphic
GRAPHICGraphic